Dr. Armando Mejía Álvarez holds a Bachelor’s degree in Biology from the Universidad Nacional Autónoma de México (UNAM), a Master’s degree in Biotechnology from CINVESTAV-IPN, and a Ph.D. in Biotechnology from UNAM. Additionally, he completed a postdoctoral fellowship in Biochemistry and Molecular Biology at the University of Wales, United Kingdom.

Since 2021, he has been a member of the Sistema Nacional de Investigadoras e Investigadores (SNII). He is the author of over 40 international peer-reviewed articles indexed in scientific databases and has presented nearly 100 papers at scientific conferences. He has advised more than 48 undergraduate, master’s, and doctoral theses.

At the institutional level, he has served as a member of the CBS Divisional Evaluation Committee (Comisión Dictaminadora Divisional de CBS) and participated in various academic committees, including those for the Graduate Program in Biotechnology, the Divisional Laboratory of Molecular Biology, and the Academic Committee for Biochemistry.

Dr. Mejía Álvarez serves as a reviewer for several renowned scientific journals, such as Bioresource Technology, Journal of the Mexican Chemical Society, Process Biochemistry, Journal of Biotechnology, and Microbial Cell Factories, among others. Additionally, he holds editorial roles in journals including Frontiers in Microbiology, Frontiers in Bioengineering and Biotechnology, and Frontiers in Environmental Science.

Regarding his professional experience, he stands out for his role as a biotechnologist specializing in genetic engineering and secondary metabolites, as well as his industry background at companies such as FEMIC S.A. de C.V., Química Agronómica de México S. de R.L., and Manomax de México S. de R.L. de C.V. He currently serves as a Full-Time Tenured Faculty Researcher (Titular C) in the Department of Biotechnology at the Universidad Autónoma Metropolitana Unidad Iztapalapa.

During his collaboration with Química Agronómica de México from 2013 to 2020, he contributed significantly to the development of sustainable technologies, such as the heterologous production of an active peptide against phytopathogens to replace chemical pesticides with environmentally friendly alternatives. Furthermore, in collaboration with BQI Eng. Gabriela León, he participated in the development of an antiviral agent against SARS-CoV-2.

His academic achievements have been recognized with awards including the Reconocimiento a la Docencia, the Estímulo a la Trayectoria Académica Sobresaliente, and the Premio a la Investigación (2023) awarded by UAM.